Competition

Refine your results

Filters

Content type

Mission

Displaying 2361 - 2380 of 4733

Press Release

Statement of FTC Chairwoman Edith Ramirez on the U.S. Supreme Court's Decision in McWane Inc. v. FTC

Date

March 21, 2016

Federal Trade Commission Chairwoman Edith Ramirez issued the following statement regarding the Supreme Court’s denial of certiorari in McWane Inc. v. FTC. The Court declined to review an April 2015...

Press Release

FTC Approves Final Order Preserving Competition Among Outpatient Dialysis Clinics in Laredo, Texas

Date

March 18, 2016

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that national kidney-dialysis chain U.S. Renal Care, Inc.’s $640 million acquisition of...

Cases and Proceedings

Rangers Renal Holding, LP; US Renal Care, Inc.; Dialysis Parent, LLC and Dialysis HoldCo, LLC, In the Matter of

To settle charges that its acquisition of DSI Renal would substantially lessen competition for outpatient dialysis services in Laredo, Texas, U.S. Renal agreed to divest three clinics to Satellite Healthcare, Inc.

Type of Action

Administrative

Last Updated

March 18, 2016

FTC Matter/File Number

151 0215

Public Statement

INNOVATE2016: The role of the FTC and federal regulators in Silicon Valley (Video)

Date

March 17, 2016

Press Release

FTC Amicus Brief Urges Appeals Court to Correct Legal Errors in District Court’s Antitrust Analysis of Reverse-Payment Agreement

Date

March 16, 2016

The Federal Trade Commission filed an amicus brief with the U.S. Court of Appeals for the Third Circuit urging the court to correct four legal errors in a district court’s antitrust analysis of an...

Amicus Briefs

In re Wellbutrin Antitrust Litigation

Date

March 11, 2016

Citation Number

15-3559, 15-3591, 15-3681, 15-3682

Federal Court

U.S. Circuit Court of Appeals for the Third Circuit

Brief of the Federal Trade Commission arguing that the district court committed multiple legal errors that should be corrected on appeal. The district court erroneously concluded that a reverse...

Text of the Amicus Brief (266.47 KB)

Public Statement

International and Crossborder Coordination and Collaboration

Date

March 10, 2016

International and Crossborder Coordination and Collaboration (58.58 KB)

Press Release

FTC Staff: Proposed Health Care Legislation in West Virginia Would Likely Be Anticompetitive and Harm Consumers

Date

March 10, 2016

Federal Trade Commission staff submitted written comments on the competitive impact of provisions in proposed legislation in West Virginia that would provide for “cooperative agreements” between...

Testimony

Prepared Statement of the Federal Trade Commission On "Oversight of the Enforcement of the Antitrust Laws"

Date

March 9, 2016

Federal Trade Commission (FTC);

Edith Ramirez, Former Chairwoman

Matter Number

P859910

Text of the Commission Testimony (95.73 KB)

Press Release

FTC Chairwoman Ramirez Testifies Before Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights

Date

March 9, 2016

Testifying on behalf of the Federal Trade Commission before the U.S. Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, Chairwoman Edith Ramirez outlined how effective...

HSR Informal Interpretations

1603001 Informal Interpretation

Date

March 3, 2016

Rule

801.10, 801.30

If multiple open market purchases are made on the same day, the buyer need not (but may) revalue its holdings more than once daily.

Original Image (69.09 KB)

Press Release

FTC Puts Conditions on Drug Manufacturer Hikma Pharmaceuticals PLC’s Proposed Acquisition of Roxane Laboratories Inc. and Boehringer Ingelheim Roxane, Inc. from Boehringer Ingelheim Corporation

Date

February 26, 2016

Drug manufacturer Hikma Pharmaceuticals PLC will sell the rights and assets for two generic drugs, and relinquish its U.S. marketing rights to a third generic drug, in order to settle FTC charges that...

Press Release

FTC Approves Modified Consent Order for Mylan N.V.

Date

February 22, 2016

The Federal Trade Commission has approved a modified final order settling charges that Mylan N.V.’s proposed hostile takeover of Perrigo Company plc would harm competition. Because Mylan failed to...

Cases and Proceedings

Mylan N. V., In the Matter of (Perrigo Company), In the Matter of

Mylan N.V. agreed to sell the rights and assets related to seven generic drugs in order to settle FTC charges that its proposed acquisition of Perrigo Company plc would be substantially reduce competition in the markets for those drugs if the merger proceeded as originally proposed.

Type of Action

Administrative

Last Updated

February 22, 2016

FTC Matter/File Number

151 0129

C-4557

Public Statement

Keynote Remarks of FTC Chairwoman Edith Ramirez

Date

February 20, 2016

Keynote Remarks of FTC Chairwoman Edith Ramirez (81.22 KB)

HSR Informal Interpretations

1602002 Informal Interpretation

Date

February 19, 2016

Rule

801.11

If a natural person has an annual statement of income and does not control any other entities - end of analysis. Whatever is on the income statement rules for purposes of determining size of person...

Original Image (48.01 KB)

HSR Informal Interpretations

1602001 Informal Interpretation

Date

February 19, 2016

Rule

802.63, Size of Transaction

For purposes of calculating the size of transaction, debt that is acquired post-bankruptcy announcement and that will be cancelled/forgiven in exchange for equity in target must be included. This is...

Original Image (59.78 KB)

Press Release

FTC Requires Drug Marketer Hikma Pharmaceuticals PLC to Divest Rights to Five Generic Injectable Drugs as a Condition of Acquiring Certain Drug Products from Ben Venue Laboratories, Inc.

Date

February 19, 2016

The Federal Trade Commission will require generic drug marketer Hikma Pharmaceuticals PLC to divest its rights and interests in five generic injectable pharmaceuticals, as part of a settlement...

Press Release

FTC Puts Conditions on Generic Drug Marketer Lupin Ltd.’s Proposed Acquisition of Gavis Pharmaceuticals LLC

Date

February 19, 2016

Generic drug manufacturers Lupin Ltd. and Gavis Pharmaceuticals LLC will sell the rights and assets for two generic drugs, one used to treat bacterial infections and the other to treat ulcerative...

Press Release

Federal Antitrust Agencies Submit Joint Statement Encouraging Massachusetts to Consider Expanding Treatment Options for Glaucoma Patients

Date

February 18, 2016

In response to a request by Massachusetts State Representative Bradley H. Jones, the Federal Trade Commission and the Department of Justice’s Antitrust Division have submitted a statement encouraging...

Displaying 2361 - 2380 of 4733

Search or browse the Legal Library

Take action

Competition Matters Blog

Search or browse the Legal Library

Take action

Technology Blog

Advice and Guidance

Take action

Servicemembers: Your tool for financial readiness

Get consumer protection basics, plain and simple

Learn how the FTC protects free enterprise and consumers

Looking for competition guidance?

Latest News

Upcoming Event

Follow us on social media

Feature

Latest Data Visualization

Featured

Meet the Chairman

Tag: Competition

Refine your results

Refine your results

Search or browse
the Legal Library

Search or browse
the Legal Library

Servicemembers:
Your tool for financial readiness